截短的 4′-硒核苷的结构-活性关系:A3 腺苷受体的活性和结合选择性

IF 4 3区 医学 Q2 CHEMISTRY, MEDICINAL
Minjae Kim, Hongseok Choi, Akshata Nayak, Sushil K. Tripathi, Vikas R. Aswar, Vidyasagar B. Gaikwad, Kenneth A. Jacobson and Lak Shin Jeong*, 
{"title":"截短的 4′-硒核苷的结构-活性关系:A3 腺苷受体的活性和结合选择性","authors":"Minjae Kim,&nbsp;Hongseok Choi,&nbsp;Akshata Nayak,&nbsp;Sushil K. Tripathi,&nbsp;Vikas R. Aswar,&nbsp;Vidyasagar B. Gaikwad,&nbsp;Kenneth A. Jacobson and Lak Shin Jeong*,&nbsp;","doi":"10.1021/acsmedchemlett.4c0034410.1021/acsmedchemlett.4c00344","DOIUrl":null,"url":null,"abstract":"<p >This study explored the impact of structural modifications on truncated 4′-selenonucleosides as ligands for the A<sub>3</sub> adenosine receptor (AR). We synthesized and evaluated a series of these compounds for their binding affinities, functional activities, and structural interactions by using computational modeling. The SAR study revealed that all compounds exhibited selective and notable hA<sub>3</sub>AR binding, among which <b>6l</b> (<i>K</i><sub>i</sub> = 5.2 nM) and <b>6m</b> (<i>K</i><sub>i</sub> = 5.7 nM) were found as the best binding compounds. The representative <i>N</i><sup>6</sup>-cyclopropyl compound <b>6m</b> was found to be a partial agonist, contrasting with the antagonist profiles of truncated 4′-oxo and 4′-thionucleosides. Computational docking highlighted <b>6m</b>’s unique interaction with Thr94 at the A<sub>3</sub>AR binding site. This research not only advances our understanding of A<sub>3</sub>AR ligand interactions but also highlights the potential of truncated 4′-selenonucleosides as effective A<sub>3</sub>AR modulators.</p>","PeriodicalId":20,"journal":{"name":"ACS Medicinal Chemistry Letters","volume":"15 9","pages":"1620–1626 1620–1626"},"PeriodicalIF":4.0000,"publicationDate":"2024-08-22","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":"{\"title\":\"Structure–Activity Relationship of Truncated 4′-Selenonucleosides: A3 Adenosine Receptor Activity and Binding Selectivity\",\"authors\":\"Minjae Kim,&nbsp;Hongseok Choi,&nbsp;Akshata Nayak,&nbsp;Sushil K. Tripathi,&nbsp;Vikas R. Aswar,&nbsp;Vidyasagar B. Gaikwad,&nbsp;Kenneth A. Jacobson and Lak Shin Jeong*,&nbsp;\",\"doi\":\"10.1021/acsmedchemlett.4c0034410.1021/acsmedchemlett.4c00344\",\"DOIUrl\":null,\"url\":null,\"abstract\":\"<p >This study explored the impact of structural modifications on truncated 4′-selenonucleosides as ligands for the A<sub>3</sub> adenosine receptor (AR). We synthesized and evaluated a series of these compounds for their binding affinities, functional activities, and structural interactions by using computational modeling. The SAR study revealed that all compounds exhibited selective and notable hA<sub>3</sub>AR binding, among which <b>6l</b> (<i>K</i><sub>i</sub> = 5.2 nM) and <b>6m</b> (<i>K</i><sub>i</sub> = 5.7 nM) were found as the best binding compounds. The representative <i>N</i><sup>6</sup>-cyclopropyl compound <b>6m</b> was found to be a partial agonist, contrasting with the antagonist profiles of truncated 4′-oxo and 4′-thionucleosides. Computational docking highlighted <b>6m</b>’s unique interaction with Thr94 at the A<sub>3</sub>AR binding site. This research not only advances our understanding of A<sub>3</sub>AR ligand interactions but also highlights the potential of truncated 4′-selenonucleosides as effective A<sub>3</sub>AR modulators.</p>\",\"PeriodicalId\":20,\"journal\":{\"name\":\"ACS Medicinal Chemistry Letters\",\"volume\":\"15 9\",\"pages\":\"1620–1626 1620–1626\"},\"PeriodicalIF\":4.0000,\"publicationDate\":\"2024-08-22\",\"publicationTypes\":\"Journal Article\",\"fieldsOfStudy\":null,\"isOpenAccess\":false,\"openAccessPdf\":\"\",\"citationCount\":\"0\",\"resultStr\":null,\"platform\":\"Semanticscholar\",\"paperid\":null,\"PeriodicalName\":\"ACS Medicinal Chemistry Letters\",\"FirstCategoryId\":\"3\",\"ListUrlMain\":\"https://pubs.acs.org/doi/10.1021/acsmedchemlett.4c00344\",\"RegionNum\":3,\"RegionCategory\":\"医学\",\"ArticlePicture\":[],\"TitleCN\":null,\"AbstractTextCN\":null,\"PMCID\":null,\"EPubDate\":\"\",\"PubModel\":\"\",\"JCR\":\"Q2\",\"JCRName\":\"CHEMISTRY, MEDICINAL\",\"Score\":null,\"Total\":0}","platform":"Semanticscholar","paperid":null,"PeriodicalName":"ACS Medicinal Chemistry Letters","FirstCategoryId":"3","ListUrlMain":"https://pubs.acs.org/doi/10.1021/acsmedchemlett.4c00344","RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q2","JCRName":"CHEMISTRY, MEDICINAL","Score":null,"Total":0}
引用次数: 0

摘要

本研究探讨了结构修饰对作为 A3 腺苷受体(AR)配体的截短 4′-硒核苷的影响。我们合成了一系列这些化合物,并通过计算建模评估了它们的结合亲和力、功能活性和结构相互作用。SAR 研究表明,所有化合物都具有选择性和显著的 hA3AR 结合力,其中 6l (Ki = 5.2 nM)和 6m(Ki = 5.7 nM)是结合力最好的化合物。研究发现,具有代表性的 N6-环丙基化合物 6m 是一种部分激动剂,与截短的 4′-氧代和 4′-硫代核苷的拮抗剂特性形成鲜明对比。计算对接突显了 6m 与 A3AR 结合位点 Thr94 的独特相互作用。这项研究不仅加深了我们对 A3AR 配体相互作用的理解,而且突出了截短的 4′-硒核苷作为有效 A3AR 调节剂的潜力。
本文章由计算机程序翻译,如有差异,请以英文原文为准。

Structure–Activity Relationship of Truncated 4′-Selenonucleosides: A3 Adenosine Receptor Activity and Binding Selectivity

Structure–Activity Relationship of Truncated 4′-Selenonucleosides: A3 Adenosine Receptor Activity and Binding Selectivity

This study explored the impact of structural modifications on truncated 4′-selenonucleosides as ligands for the A3 adenosine receptor (AR). We synthesized and evaluated a series of these compounds for their binding affinities, functional activities, and structural interactions by using computational modeling. The SAR study revealed that all compounds exhibited selective and notable hA3AR binding, among which 6l (Ki = 5.2 nM) and 6m (Ki = 5.7 nM) were found as the best binding compounds. The representative N6-cyclopropyl compound 6m was found to be a partial agonist, contrasting with the antagonist profiles of truncated 4′-oxo and 4′-thionucleosides. Computational docking highlighted 6m’s unique interaction with Thr94 at the A3AR binding site. This research not only advances our understanding of A3AR ligand interactions but also highlights the potential of truncated 4′-selenonucleosides as effective A3AR modulators.

求助全文
通过发布文献求助,成功后即可免费获取论文全文。 去求助
来源期刊
ACS Medicinal Chemistry Letters
ACS Medicinal Chemistry Letters CHEMISTRY, MEDICINAL-
CiteScore
7.30
自引率
2.40%
发文量
328
审稿时长
1 months
期刊介绍: ACS Medicinal Chemistry Letters is interested in receiving manuscripts that discuss various aspects of medicinal chemistry. The journal will publish studies that pertain to a broad range of subject matter, including compound design and optimization, biological evaluation, drug delivery, imaging agents, and pharmacology of both small and large bioactive molecules. Specific areas include but are not limited to: Identification, synthesis, and optimization of lead biologically active molecules and drugs (small molecules and biologics) Biological characterization of new molecular entities in the context of drug discovery Computational, cheminformatics, and structural studies for the identification or SAR analysis of bioactive molecules, ligands and their targets, etc. Novel and improved methodologies, including radiation biochemistry, with broad application to medicinal chemistry Discovery technologies for biologically active molecules from both synthetic and natural (plant and other) sources Pharmacokinetic/pharmacodynamic studies that address mechanisms underlying drug disposition and response Pharmacogenetic and pharmacogenomic studies used to enhance drug design and the translation of medicinal chemistry into the clinic Mechanistic drug metabolism and regulation of metabolic enzyme gene expression Chemistry patents relevant to the medicinal chemistry field.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
copy
已复制链接
快去分享给好友吧!
我知道了
右上角分享
点击右上角分享
0
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:604180095
Book学术官方微信